By SquaredTown on November 12, 2025
BOSTON, Nov. 12, 2025 /PRNewswire/ -- Modulight Biotherapeutics, developer of novel optogenetic platform for the treatment of neurological disorders, announced today the closing of its Seed funding round raising $12.2 million. The Seed round was led by Jibe Ventures and LocalGlobe, with...